Processa Pharmaceuticals, Inc. Payments of Stock Issuance Costs
Processa Pharmaceuticals, Inc. (PCSA) reported Payments of Stock Issuance Costs of $2.10 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-30
- Processa Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2018-12-31 was $90.41K.
- Processa Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2018-09-30 was -$1.53K.
- Processa Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2018-06-30 was $218.42K.
- Processa Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2020 was $2.10M.
- Processa Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2018 was $308.83K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $2.10M 10-K · filed 2022-03-30 | ||||
| 2018-12-31 | $90.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $88.88K derived: sum of 2 quarters · filed 2020-03-06 | $307.30K derived: sum of 3 quarters · filed 2020-03-06 | $308.83K 10-K · filed 2020-03-06 | |
| 2018-09-30 | -$1.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $216.89K derived: sum of 2 quarters · filed 2019-11-14 | $218.42K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $218.42K 10-Q · filed 2019-11-14 | $219.95K 10-Q · filed 2019-08-14 | $219.95K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |